Weiss Ratings Reiterates Sell (D-) Rating for 2seventy bio (NASDAQ:TSVT)
2seventy bio (NASDAQ:TSVT – Get Free Report)‘s stock had its “sell (d-)” rating reaffirmed by research analysts at Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports. Other equities research analysts also recently issued research reports about the company. Leerink Partners restated a “market perform” rating and set a $5.00 target price (down […]
2seventy bio (NASDAQ:TSVT – Get Free Report)‘s stock had its “sell (d-)” rating reaffirmed by research analysts at Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports. Other equities research analysts also recently issued research reports about the company. Leerink Partners restated a “market perform” rating and set a $5.00 target price (down […]
